These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8068512)
1. Mycobacterial and fungal infections of bone and joints. Meier JL Curr Opin Rheumatol; 1994 Jul; 6(4):408-14. PubMed ID: 8068512 [TBL] [Abstract][Full Text] [Related]
2. Mycobacterial and fungal infections of bone and joints. Meier JL; Beekmann SE Curr Opin Rheumatol; 1995 Jul; 7(4):329-36. PubMed ID: 7547111 [TBL] [Abstract][Full Text] [Related]
3. Treatment of fungal infections in the bones and joints with ketoconazole. Horsburgh CR; Cannady PB; Kirkpatrick CH J Infect Dis; 1983 Jun; 147(6):1064-9. PubMed ID: 6304204 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the clinical characteristics of Mycobacterium tuberculosis and nontuberculous mycobacteria patients with joint involvement. Yun JH; Sung H; Kim T; Hong SI; Chong YP; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO Infection; 2015 Apr; 43(2):207-9. PubMed ID: 25623639 [TBL] [Abstract][Full Text] [Related]
8. Granulomatous infections of bones and joints. Pritchard DJ Orthop Clin North Am; 1975 Oct; 6(4):1029-47. PubMed ID: 1178158 [TBL] [Abstract][Full Text] [Related]
9. What's new in mycotic bone and joint diseases? Schwarz J Pathol Res Pract; 1984 Jul; 178(6):617-34. PubMed ID: 6483686 [TBL] [Abstract][Full Text] [Related]
10. Mycobacterial and fungal forms of arthritis. Golden HE; Parker RH Mod Treat; 1969 Sep; 6(5):1117-29. PubMed ID: 5361637 [No Abstract] [Full Text] [Related]
12. Newer developments in therapy for endemic mycoses. Kauffman CA Clin Infect Dis; 1994 Aug; 19 Suppl 1():S28-32. PubMed ID: 7948568 [TBL] [Abstract][Full Text] [Related]
13. [Mycobacterial infections in joints]. Turgeman N; Marcus JH; Nishmi P Harefuah; 1979 Mar; 96(5):235-7. PubMed ID: 540811 [No Abstract] [Full Text] [Related]
14. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Straus WL; Ostroff SM; Jernigan DB; Kiehn TE; Sordillo EM; Armstrong D; Boone N; Schneider N; Kilburn JO; Silcox VA; LaBombardi V; Good RC Ann Intern Med; 1994 Jan; 120(2):118-25. PubMed ID: 8256970 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS]. Pulido F; Iribarren JA; Kindelan JM; Moreno S Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616 [TBL] [Abstract][Full Text] [Related]
16. Oral azole drugs as systemic antifungal therapy. Como JA; Dismukes WE N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088 [TBL] [Abstract][Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
18. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]